Company Filing History:
2 out of 74 
1 out of 61 
1 out of 8 Years Active: 2019-2021
Title: The Innovations of Robert Rieben
Introduction
Robert Rieben is an accomplished inventor based in Hinterkappelen, Switzerland. He holds two patents that focus on significant advancements in medical technology. His work primarily addresses the treatment and prevention of remote ischemia-reperfusion injury, showcasing his commitment to improving patient outcomes.
Latest Patents
Rieben's latest patents include a contact activation system inhibitor, preferably a C1INH, for use in the treatment and/or prevention of remote ischemia-reperfusion injury (IRI). This invention involves administering the contact activation system inhibitor to an individual, aiming to mitigate the effects of IRI. His innovative approach has the potential to enhance therapeutic strategies in clinical settings.
Career Highlights
Throughout his career, Robert Rieben has made significant contributions to the field of medical research. He has worked with notable organizations, including CSL Behring GmbH and Universität Bern. His experience in these institutions has allowed him to develop and refine his inventions, furthering the impact of his work in the medical community.
Collaborations
Rieben has collaborated with esteemed colleagues such as Rolf Spirig and Sylvia Miescher. These partnerships have enriched his research and contributed to the successful development of his patents.
Conclusion
Robert Rieben's innovative work in the treatment and prevention of remote ischemia-reperfusion injury highlights his dedication to advancing medical technology. His contributions are poised to make a lasting impact in the field of healthcare.